Results 231 to 240 of about 1,410,069 (283)

Quemliclustat and chemotherapy with or without zimberelimab in metastatic pancreatic adenocarcinoma: a randomized phase 1 trial. [PDF]

Nat Med
Wainberg ZA, Manji GA, Bahary N, Ulahannan SV, Pant S, Spigel DR, Uboha NV, Oberstein PE, Saeed A, Beagle B, Kim JY, Wang N, Weeder B, Shitole S, Mrouj K, Scott JR, Ensign LG, DiRenzo DM, Walters MJ, Wu W, Kaplan A, Cho S, Kabbarah O, O'Reilly EM.   +23 more
europepmc   +1 more source

A small-molecule inverse agonist of PPARγ for advanced solid tumors: a phase 1 trial. [PDF]

Nat Med
Galsky MD, Mantia C, Bowden M, Bellmunt J, Garmezy B, Iyer G, Petrylak DP, Rasco D, Gupta S, Rodriguez-Rivera I, Mikhailov Y, Joshi A, Nguyen PA, Kakrecha B, Tepper J, Costa AM, McCrone C, Rossi AP, Mertz JA, Gjini E, Meyers ML, Milowsky MI, Gao X.   +22 more
europepmc   +1 more source

How enfortumab vedotin plus pembrolizumab affects the quality of life of people with advanced urothelial cancer compared with platinum-based chemotherapy: a plain language summary of patient-reported outcomes from the EV-302 study. [PDF]

Future Oncol
Gupta S, Loriot Y, Van der Heijden MS, Bedke J, Valderrama BP, Kikuchi E, Fléchon A, Petrylak D, De Santis M, Galsky MD, Lee JL, Swami U, Sridhar SS, De Giorgi U, Wright P, Shih V, Lu YT, Guan X, Dillon R, Shetty A, Homet Moreno B, Beaumont JL, Purnajo I, McManus S, Powles T.   +24 more
europepmc   +1 more source

Editorial: The role of nano-therapeutics in precision cancer medicine. [PDF]

Front Bioeng Biotechnol
Wang S, Thach T, De Vita A.
europepmc   +1 more source

Crossing the finish line towards a disease-modifying treatment for Angelman syndrome. [PDF]

J Neurodev Disord
Judson MC, de Almeida LP, Burdine RD, Chamberlain SJ, Deverman BE, Distel B, Ehlers MD, Jalazo E, Kushner SA, Nespeca M, Sanders SJ, Scheffner M, Yi JJ, Zylka MJ, Elgersma Y, Philpot BD.   +15 more
europepmc   +1 more source

Bexotegrast for treatment of idiopathic pulmonary fibrosis (BEACON-IPF): study protocol for a multinational, phase 2b/3, double-blind, randomised, multicentre, controlled trial. [PDF]

BMJ Open Respir Res
Wuyts WA, Lancaster L, Maher TM, Ryerson CJ, Kreuter M, Corte TJ, Valenzuela C, Barnes CN, Lefebvre ÉA, Cosgrove GP, Flaherty KR, Richeldi L, Cottin V.   +12 more
europepmc   +1 more source

Correction to "A Meta-Analysis of the Incidence of Adverse Reactions of Statins in Various Diseases". [PDF]

Cardiovasc Ther
europepmc   +1 more source